Pinnacle Bancorp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $517K | Buy |
21,473
+2,089
| +11% | +$54.6K | 0.13% | 141 |
|
|
2026
Q1 | $544K | Sell |
19,384
-700
| -3% | -$18.6K | 0.16% | 115 |
|
|
2025
Q4 | $500K | Hold |
20,084
| – | – | 0.15% | 122 |
|
|
2025
Q3 | $512K | Buy |
20,084
+1,624
| +9% | +$40.1K | 0.15% | 123 |
|
|
2025
Q2 | $447K | Sell |
18,460
-800
| -4% | -$18.7K | 0.14% | 134 |
|
|
2025
Q1 | $488K | Sell |
19,260
-435
| -2% | -$11.4K | 0.16% | 118 |
|
|
2024
Q4 | $523K | Sell |
19,695
-6,896
| -26% | -$187K | 0.17% | 109 |
|
|
2024
Q3 | $770K | Buy |
26,591
+84
| +0.3% | +$2.45K | 0.21% | 77 |
|
|
2024
Q2 | $742K | Sell |
26,507
-5,402
| -17% | -$149K | 0.22% | 70 |
|
|
2024
Q1 | $885K | Buy |
31,909
+5,111
| +19% | +$142K | 0.26% | 63 |
|
|
2023
Q4 | $772K | Sell |
26,798
-713
| -3% | -$21.6K | 0.25% | 65 |
|
|
2023
Q3 | $913K | Sell |
27,511
-951
| -3% | -$33.6K | 0.32% | 51 |
|
|
2023
Q2 | $1.04M | Buy |
28,462
+1,735
| +6% | +$67.5K | 0.36% | 46 |
|
|
2023
Q1 | $1.09M | Buy |
26,727
+78
| +0.3% | +$3.37K | 0.4% | 44 |
|
|
2022
Q4 | $1.36M | Sell |
26,649
-1,350
| -5% | -$64.7K | 0.53% | 37 |
|
|
2022
Q3 | $1.23M | Sell |
27,999
-92
| -0.3% | -$4.47K | 0.53% | 35 |
|
|
2022
Q2 | $1.47M | Buy |
28,091
+2,149
| +8% | +$110K | 0.61% | 32 |
|
|
2022
Q1 | $1.34M | Sell |
25,942
-679
| -3% | -$35.2K | 0.47% | 39 |
|
|
2021
Q4 | $1.57M | Sell |
26,621
-6,831
| -20% | -$338K | 0.56% | 33 |
|
|
2021
Q3 | $1.44M | Buy |
33,452
+4,365
| +15% | +$193K | 0.58% | 32 |
|
|
2021
Q2 | $1.14M | Sell |
29,087
-468
| -2% | -$18.2K | 0.52% | 31 |
|
|
2021
Q1 | $1.07M | Sell |
29,555
-1,050
| -3% | -$37.3K | 0.52% | 32 |
|
|
2020
Q4 | $1.13M | Sell |
30,605
-2,031
| -6% | -$74.5K | 0.69% | 29 |
|
|
2020
Q3 | $1.14M | Sell |
32,636
-3,333
| -9% | -$117K | 0.8% | 26 |
|
|
2020
Q2 | $1.12M | Buy |
35,969
+2,685
| +8% | +$91.2K | 0.83% | 25 |
|
|
2020
Q1 | $1.03M | Hold |
33,284
| – | – | 0.88% | 23 |
|
|
2019
Q4 | $1.24M | Sell |
33,284
-294
| -0.9% | -$10.5K | 0.86% | 24 |
|
|
2019
Q3 | $1.15M | Sell |
33,578
-86
| -0.3% | -$3.13K | 0.65% | 28 |
|
|
2019
Q2 | $1.38M | Sell |
33,664
-369
| -1% | -$14.7K | 0.78% | 16 |
|
|
2019
Q1 | $1.37M | Sell |
34,033
-274
| -0.8% | -$11K | 0.8% | 18 |
|
|
2018
Q4 | $1.42M | Buy |
+34,307
| New | +$1.42M | 0.87% | 16 |
|
|
2017
Q1 | $1.12M | Buy |
+34,439
| New | +$1.09M | 0.79% | 18 |
|
Other funds holding PFE
Pinnacle Bancorp's PFE Position: Q2 2026 in Review
Pinnacle Bancorp increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $54.6K and bringing the position to 21,473 shares worth $517K. The position accounts for 0.13% of the portfolio, ranked #141.
Pinnacle Bancorp first reported a position in PFE in Q1 2017 and has held it in 32 quarters since. The position peaked at $1.57M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pinnacle Bancorp held 21,473 shares of Pfizer worth $517K as of Q2 2026.
- Pinnacle Bancorp bought 2,089 Pfizer shares in Q2 2026, an estimated $54.6K.
- Pfizer made up 0.13% of Pinnacle Bancorp's portfolio in Q2 2026, its #141 holding.
- Pinnacle Bancorp first reported a position in Pfizer in Q1 2017 and has held it in 32 quarters since.
- Pinnacle Bancorp's Pfizer position peaked at $1.57M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.